Cable Hill Partners, LLC - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
Cable Hill Partners, LLC ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$12,000
+300.0%
508
+370.4%
0.00%
+300.0%
Q4 2018$3,0000.0%1080.0%0.00%0.0%
Q3 2018$3,000
-76.9%
108
-67.0%
0.00%
-80.0%
Q2 2018$13,000
-23.5%
327
-47.8%
0.01%
-28.6%
Q1 2018$17,000
+88.9%
627
+25.4%
0.01%
+75.0%
Q4 2017$9,000
+12.5%
5000.0%0.00%0.0%
Q3 2017$8,0005000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders